Log in to search using one of your social media accounts:

 

Golden 100: Xymogen
This CEO once spent two summers with an uncle who captained a Naval submarine in Key West. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 23, 2017 Category: Biotechnology Authors: Denise Hicks Source Type: news

Oregon Health Authority gets a new, but familiar, director
Gov. Kate Brown announced that Patrick Allen, whom she appointed as acting director of the Oregon Health Authority about four weeks ago, will remain on the job on a permanent basis. "Each Oregonian has a right to a healthy, independent life that allows them to succeed," Brown said in a statement. "To achieve this goal, the Oregon Health Authority must be capable of maintaining a high value and sustainable health care system. Pat has already proven to be a responsible steward of taxpayer dollars… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 23, 2017 Category: Biotechnology Authors: Elizabeth Hayes Source Type: news

Zenefits' big switch: From fighting brokers to serving them
After brokering insurance without a license and getting fined for it, Zenefits is switching gears to make technology for brokers rather than compete with them. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 22, 2017 Category: Biotechnology Authors: Antoinette Siu Source Type: news

VA gets new interim director
The VA Western New York Healthcare System has brought in a new leader to replace Brian Stiller. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 22, 2017 Category: Biotechnology Authors: Tracey Drury Source Type: news

Washington could lose up to $110 billion in health care funding under Graham-Cassidy plan
The Republican health care proposal is estimated to reduce federal health care spending supporting Washingtonians by $110 billion by 2036. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 22, 2017 Category: Biotechnology Authors: Coral Garnick Source Type: news

Could this East Bay generic drug maker have the urge to merge?
A rumored merger including an East Bay drug company — a major player in the generic drug market — makes sense, an analyst says, but only after looking at a potential $100 million in cuts. Impax Laboratories Inc. (NASDAQ: IPXL) of Hayward is in talks to merge with privately held Amneal Pharmaceuticals LLC, Reuters and the Wall Street Journal repo rted. The deal would value Impax at $2 billion or more. The possibility of a deal comes as the generic drug business further consolidates in the face… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 22, 2017 Category: Biotechnology Authors: Ron Leuty Source Type: news

Aegerion finalizes $40M settlement, guilty plea in drug misbranding case
Aegerion Pharmaceuticals, a Cambridge biotech that merged last year with a Canadian firm, has finalized a $40 million settlement to resolve civil and criminal charges over its marketing of a cholesterol drug. The U.S. Attorney’s Office in Boston said Friday that Aegerion, which is now a subsidiary of Vancouver-based Novelion Therapeutics (Nasdaq: NVLN), will plead guilty to two misdemeanor misbranding violations. The company initially disclosed last year that it expected to enter a guilty plea… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 22, 2017 Category: Biotechnology Authors: Max Stendahl Source Type: news

Aegerion finalizes $40M settlement, guilty plea in drug misbranding case
Aegerion Pharmaceuticals, a Cambridge biotech that merged last year with a Canadian firm, has finalized a $40 million settlement to resolve civil and criminal charges over its marketing of a cholesterol drug. The U.S. Attorney’s Office in Boston said Friday that Aegerion, which is now a subsidiary of Vancouver-based Novelion Therapeutics (Nasdaq: NVLN), will plead guilty to two misdemeanor misbranding violations. The company initially disclosed last year that it expected to enter a guilty plea… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - September 22, 2017 Category: Health Management Authors: Max Stendahl Source Type: news

Chicago physical therapy business buys The Work Center
Athletico Physical Therapy has acquired St. Louis-based The Work Center, which specializes in providing physical and occupational therapy for work-related injuries. Terms of the deal were not disclosed. The sale closed last week but was announced Friday, an Athletico spokeswoman said. The privately held companies do not disclose their revenue. Ronald Rucker and Angela Drumm of Carmody MacDonald PC served as legal counsel for The Work Center in the transaction . The Work Center has nine clinics,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 22, 2017 Category: Biotechnology Authors: Diana Barr Source Type: news

Behind new Obamacare repeal vote: ‘Furious’ Republican donors
The backlash from big donors as well as the grass roots has panicked Senate Republicans and is part of the motivation behind the sudden zeal to take one last crack at repealing the health care law before the end of the month. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 22, 2017 Category: Biotechnology Authors: By Carl Hulse Source Type: news

Former Akebia employee jailed after insider trading prosecutors call him 'unhinged'
Schultz Chan is accused of passing inside information about one of the Cambridge firm's drug trials to another biotech industry employee. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 22, 2017 Category: Biotechnology Authors: Max Stendahl Source Type: news

Former Akebia employee jailed after insider trading prosecutors call him 'unhinged'
Schultz Chan is accused of passing inside information about one of the Cambridge firm's drug trials to another biotech industry employee. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 22, 2017 Category: Pharmaceuticals Authors: Max Stendahl Source Type: news

Failed growth hormone trial shrinks Peninsula drug company's stock more than 80%
The company lost more than 80 percent of its value by mid-day Friday after its attempt to tap a $3 billion growth hormone market failed a late-stage clinical trial. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 22, 2017 Category: Biotechnology Authors: Ron Leuty Source Type: news

​Baptist Health South Florida to open express health care center in Doral
The health system will locate the center in the Downtown Doral development. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 22, 2017 Category: Biotechnology Authors: Debora Lima Source Type: news

Boasting Buffalo: Joanne Haefner promotes healthy communities
Joanne Haefner has spent 25 years in health care as both a nurse practitioner and administrator. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 22, 2017 Category: Biotechnology Authors: Tracey Drury Source Type: news

UTHSC partners with Southern Research on drug discovery
The University of Tennessee Health Sciences Center, or UTHSC, has formed a partnership with Birmingham's Southern Research to advance promising research that could lead to new drugs to address unmet medical needs. The program links the drug discovery and development expertise of Southern Research with UTHSC’s research network, which spans four campuses and has been involved in sponsored programs valued at $240.5 million in 2016. “We believe there are a lot of synergies between the two organizations,” … (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 22, 2017 Category: Biotechnology Authors: Tyler Patchen Source Type: news

GOP health care bill could cost Minnesota billions
Minnesota stands to come out a lot worse under the latest Republican effort to repeal the Affordable Care Act, if the last-ditch effort succeeds next week. The Star Tribune reports on the effects of the proposed legislation, which would replace federal health funding with block grants to states. Washingto, D.C.-based health care consulting firm Avalere Health crunched the numbers and found that Minnesota would receive $8 billion less over 10 years un der the Graham-Cassidy bill than it gets now. Moreover,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 22, 2017 Category: Biotechnology Authors: Mark Reilly Source Type: news

NuVasive acquires startup with Duke University roots
Vertera Spine, a startup with research origins at Duke University and the Georgia Institute of Technology, has been acquired by San Diego-based medical device company NuVasive (Nasdaq: NUVA), which reported revenues of more than $960 million last year. Ken Gall, chair of Duke’s Department of Mechanical Engineering and Materials Science, co-founded Vertera in 2013 while working as a professor at Georgia Tech. “NuVasive will use this to really dominate the market,” he says. “What we liked… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 22, 2017 Category: Biotechnology Authors: Jennifer Henderson Source Type: news

Is Amazon eyeing mail-order pharmacy market?
Amazon reportedly may be in talks with pharmacy benefit managers about possibly entering the mail-order pharmacy industry. According to analysts with investment bank Leerink Partners who spoke with pharmacy executives, Amazon could pursue a mail-order pharmacy initially focused on uninsured customers or people with high deductibles who mainly pay cash for their prescriptions, Axios reports. While it would take at lea st 18 months for Amazon to get the drug licenses it needs across the U.S., the… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 22, 2017 Category: Biotechnology Authors: Angela Mueller Source Type: news

Nurse pleads guilty in Medicaid fraud case
A nurse in has pleaded guilty to illegal remunerations related to a broader Medicaid fraud case in the state. Christine Hicks Thomas, 62, of Murfreesboro, faces up to five years in prison as well as $25,000 in fines and three years of supervised release, according to the U.S. Attorney’s Office for the Eastern District of North Carolina. As part of her plea agreement, she has agreed “to surrender her n ursing license, to surrender any interest she has in companies that bill the government for… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 22, 2017 Category: Biotechnology Authors: Jennifer Henderson Source Type: news

Humana scores really high in this ranking of the country's healthiest employers
Humana Inc. landed in the top five of a ranking of the healthiest employers in the United States. The list, compiled by the Healthiest Employers, places the Louisville-based insurance giant at No. 3 out of the 100 companies it singled out for their commitment to health. About Humana, the Springbuk Inc. initiative said: "Humana, has tracked population health metrics since 2011. Key successes of their program include employee biometric screening compliance of 87 percent, 52 percent of employees… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 22, 2017 Category: Biotechnology Authors: Shea Van Hoy Source Type: news

Largest Milwaukee-area nursing homes
The List features the largest nursing homes in Milwaukee, Waukesha, Washington, Walworth, Ozaukee, Racine and Kenosha counties ranked by licensed bed capacity. The information is from the 2016 Consumer Information Report from the Wisconsin Department of Health Services. Ties are broken by the average number of patients. The web list features seven additional skilled care facilities. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 22, 2017 Category: Biotechnology Source Type: news

Executive profile: Katrina Robinson Lee of The Healthcare Institute LLC
"In all things, growth is the strategy. Whether it is serving your customers, improving operations or growing your bottom line." (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 22, 2017 Category: Biotechnology Source Type: news

Mankind Pharma pulls out Navratri-linked ad campaign featuring Sunny Leone
Navratri hoardings campaign was not meant to hurt anyone's sentiments and was immediately withdrawn, said the company. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 22, 2017 Category: Pharmaceuticals Source Type: news

Soon, Centre to add 100 more drugs to over-the-counter list
Drugs likely to get off prescription will initially include those commonly used for cold, cough and analgesics such as paracetamol and ibuprofen. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 22, 2017 Category: Pharmaceuticals Source Type: news

The hidden costs of health care
Taxes, fees and unpaid dollars are all contributing to rising premiums for health insurance and there's not much the companies or the consumer can do about it. OR Why is my health insurance premium so high? (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 22, 2017 Category: Biotechnology Authors: Tracey Drury Source Type: news

Dell Medical School disruptors: Picking the next generation of doctors
Joel Daboub spends his days scouting for top talent. No, he ’s not in pro sports or the tech sector. As director of admissions for Dell Medical School, his team sorts through thousands of applications honing in on candidates who will best carry the mantle for the first ground-up medical school built at a major U.S. university in 50 years. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 22, 2017 Category: Biotechnology Authors: Jan Buchholz Source Type: news

Pharma stocks in demand as market looks for safety
Analysts now find the risk-reward attractive for large-cap quality pharma stocks. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 22, 2017 Category: Pharmaceuticals Source Type: news

Crowning the 'King of the Crops': Sequencing the white Guinea yam genome
(Earlham Institute) An international collaboration involving the Earlham Institute, Norwich, UK, and the Iwate Biotechnology Research Centre, Japan, has for the first time provided a genome sequence for the white Guinea yam, a staple crop with huge economic and cultural significance on the African continent and a lifeline for millions of people. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - September 22, 2017 Category: Biology Source Type: news

Inspiring stories from 5 aspiring doctors at Austin's Dell Medical School
The Dell Medical School ’s mission is to turn the U.S. health care business model on its head — and that job is in the hands of 100 young women and men who make up the first- and second-year class of students. Staff writer Jan Buchholz delves into why they want to shake up the system. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 22, 2017 Category: Biotechnology Authors: Jan Buchholz Source Type: news

Dell Medical School disruptors: Khaled Abdelrahman
Dell Medical School student profiles: 23-year-old Khaled Abdelrahman of Corpus Christi. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 22, 2017 Category: Biotechnology Authors: Jan Buchholz Source Type: news

Dell Medical School disruptors: Ruth Sanchez
Profiles of Dell Medical School students: 23-year-old Ruth Sanchez of Austin. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 22, 2017 Category: Biotechnology Authors: Jan Buchholz Source Type: news

Dell Medical School disruptors: Alexander Wright
Profiles of the first classes at Dell Medical School: 24-year-old Alexander Wright of Friendswood. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 22, 2017 Category: Biotechnology Authors: Jan Buchholz Source Type: news

Dell Medical School disruptors: Saloni Naik
Editor's note: This story is one part of a package looking at the first classes at Dell Medical School. Go here to read the rest. Like many college students, a business degree seemed like a wise pursuit to Saloni Naik, who grew up in the Dallas area. Two of her uncles are physicians so a random thought about becoming a doctor crossed her mind. “But I thought getting a business degree would be the most useful,” Naik sai d. While attending UT, Naik was well aware that a medical school was in… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 22, 2017 Category: Biotechnology Authors: Jan Buchholz Source Type: news

Dell Medical School disruptors: Taylor Smyth
Profiles of Dell Medical School students: 27-year-old Taylor Smyth of Nashville, Tennessee. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 22, 2017 Category: Biotechnology Authors: Jan Buchholz Source Type: news

Tiny diamonds could become best friends to youths with cleft palates
This study showed that our method has a contained, targeted and sustained effect, so we’re very excited about it,” Hong said.Previous experiments showed nanodiamonds to be safe within the body and to be excreted normally. Similarly, earlier work demonstrated that enzymes break down hydrogel.The researchers plan to continue laboratory studies and hope to bring their treatment to clinical trials. Their approach has implications for treating other craniofacial conditions and sleep apnea, as well as healing wounds and bone injuries.Other authors of the study were Dong-Keun Lee, Lawrence Lin, Hsin Chuan Pan, Deborah...
Source: UCLA Newsroom: Health Sciences - September 22, 2017 Category: Universities & Medical Training Source Type: news

Cavion starts enrolment in Phase II trial of CX-8998 for essential tremor
US-based biotechnology firm Cavion has started patient enrolment in a Phase II clinical trial (T-CALM Study) of CX-8998 to treat essential tremor (ET). (Source: Drug Development Technology)
Source: Drug Development Technology - September 21, 2017 Category: Pharmaceuticals Source Type: news

Shire reports positive data from Phase III trial of Intuniv for ADHD
Irish biotechnology firm Shire and its Japanese partner Shionogi have reported positive top-line results from a Phase III clinical trial of Intuniv (guanfacine hydrochloride prolonged release) in adults with attention deficit hyperactivity disorder ( … (Source: Drug Development Technology)
Source: Drug Development Technology - September 21, 2017 Category: Pharmaceuticals Source Type: news

Audentes commences dosing in Phase I/II trial for myotubular myopathy
US-based biotechnology firm Audentes Therapeutics has commenced patient dosing in the Phase I/II ASPIRO clinical trial of its product candidate AT132 to treat X-linked myotubular myopathy (XLMTM). (Source: Drug Development Technology)
Source: Drug Development Technology - September 21, 2017 Category: Pharmaceuticals Source Type: news

Future Froedtert affiliate United Hospital System plans Pleasant Prairie clinic
United Hospital System in Kenosha, which will soon broaden its partnership with Froedtert& the Medical College of Wisconsin, plans a 50,000-square-foot clinic as part of a new development in Pleasant Prairie. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 21, 2017 Category: Biotechnology Authors: Rich Kirchen Source Type: news

Mayor Bowser releases new 'roadmap' for D.C. health investments
The District has a new "roadmap" to guide its approval process for any future health care investments or construction projects, Mayor Muriel Bowser announced during a news conference this week. And hospitals and other medical providers that depend on regulatory approval for major health investments that require what are called "certificate of need" approvals would do well to pay close attention to the new 188-page report. "This directly informs the Department of Health and the committee 's consideration… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 21, 2017 Category: Biotechnology Authors: Tina Reed Source Type: news

Here's where HCA will open 4 urgent care centers and create 40 jobs
Each facility will hire roughly 10 staff members. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 21, 2017 Category: Biotechnology Authors: Veronica Brezina Source Type: news

C-Suite Awards: Sy Griffey
This scientist cites communication as one of the most powerful tools for leading a biotech company. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 21, 2017 Category: American Health Authors: Tricia Schwennesen Source Type: news

Friendship Village expands with new management
Friendship Village has ended a 40-plus year management contract with Des Moines, Iowa-based Life Care Services and formed a new parent company to self-manage its senior living communities in Chesterfield and Sunset Hills. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 21, 2017 Category: Biotechnology Authors: Angela Mueller Source Type: news

Kaiser's Washington President Susan Mullaney wants to move health care from hospitals
Kaiser Permanente is doubling down in the Puget Sound Region after it its deal to acquire Group Health closed early this year. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 21, 2017 Category: Biotechnology Authors: Coral Garnick Source Type: news

Southern Research partners with the University of Tennessee on drug development
The University of Tennessee Health Sciences Center, or UTHSC, has formed a partnership with Birmingham's Southern Research to advance promising research that could lead to new drugs to address unmet medical needs. The program links the drug discovery and development expertise of Southern Research with UTHSC’s research network, which spans four campuses and has been involved in sponsored programs valued at $240.5 million in 2016. “We believe there are a lot of synergies between the two organizations,” … (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 21, 2017 Category: Biotechnology Authors: Tyler Patchen Source Type: news

Delaware County sues opioid manufacturers
'We are sending a message to the Big Pharma companies.' (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 21, 2017 Category: Biotechnology Authors: John George Source Type: news

BioCryst scores FDA approval on flu treatment for children
On the heels of an $80 million public offering, Research Triangle Park-based BioCryst Pharmaceuticals (Nasdaq: BCRX) has landed U.S. Food and Drug Administration approval for its injectable flu treatment in pediatric patients. BioCryst submitted its supplemental new drug application for RAPIVAB (peramivir injection) earlier this year, with the FDA ultimately granting a priority review. In 2014, the FDA approved RAPIVAB for treating adults with the flu and the firm has also been approved in a number… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 21, 2017 Category: Biotechnology Authors: Jennifer Henderson Source Type: news

New UA president ready to take medical school to next level
Cardiac surgeon brings medical experience to growing medical school (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 21, 2017 Category: Biotechnology Authors: Angela Gonzales Source Type: news

Georgia Medicaid could get short-term boost from ACA replacement
Georgia and other states that did not expand Medicaid coverage through Obamacare would receive an increase in federal health-care funding under a replacement to the Affordable Care Act the U.S. Senate is expected to take up next week. However, a per-enrollee cap on Medicaid funding included in the bill would offset at least some of those gains. Those are the findings of an analysis released Thursday by the Kaiser Family Foundation, a non-partisan nonprofit that focuses on health policy. The legislation,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 21, 2017 Category: Biotechnology Authors: Dave Williams Source Type: news